原发灶不明骨髓转移癌25例临床分析  

Clinical analysis of 25 cases of MCBM with CUP

作　　者：季发和 朴瑛 谢晓冬 郑振东 JI Fahe;PIAO Ying;XIE Xiaodong;ZHENG Zhendong(Department of Oncology,General Hospital of Northern Theater Command of PLA,Liaoning Shenyang 110840,China)

机构地区：[1]中国人民解放军北部战区总医院肿瘤科,辽宁沈阳110840

出　　处：《现代肿瘤医学》2022年第23期4362-4364,共3页Journal of Modern Oncology

摘　　要：目的:探讨原发灶不明骨髓转移癌的病例特点、治疗情况及预后。方法:对纳入的25例患者进行回顾性分析其各自的临床特点、治疗过程以及生存情况。结果:25例患者中位总生存期为6个月。初诊时是否伴有血液学症状、病理类型、治疗方式以及接受治疗时间对患者生存有显著差异。治疗方式、家庭支持强度是影响预后的独立因素。结论:原发灶不明骨髓转移癌是临床少见的疾病,给予积极的综合治疗,加强社会家庭的支持强度可能会改善其预后。Objective:To study the characteristics of cases,treatment and prognosis of metastatic carcinoma of bone marrow(MCBM)with carcinoma of unknown primary origin(CUP).Methods:The clinical characteristics,treatment process and survival of 25 patients were retrospectively analyzed.Results:The median overall survival of 25 patients was 6 months.Hematological symptoms,pathological type,treatment method,and duration of treatment had significant differences in patient survival.Treatment method and family support intensity were independent factors affecting prognosis.Conclusion:MCBM with CUP is a rare disease.Aggressive combination therapy and enhanced support intensity of society and family may improve the prognosis.

关 键 词：原发灶不明癌 骨髓转移癌 治疗 预后 

分 类 号：R730.5[医药卫生—肿瘤]